T‐cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection
dc.contributor.author | Clayton, Linda K. | en_US |
dc.contributor.author | Ghendler, Yoseph | en_US |
dc.contributor.author | Mizoguchi, Emiko | en_US |
dc.contributor.author | Patch, Raymond J. | en_US |
dc.contributor.author | Ocain, Timothy D. | en_US |
dc.contributor.author | Orth, Kim | en_US |
dc.contributor.author | Bhan, Atul K. | en_US |
dc.contributor.author | Dixit, Vishva M. | en_US |
dc.contributor.author | Reinherz, Ellis L. | en_US |
dc.date.accessioned | 2014-01-08T20:34:14Z | |
dc.date.available | 2014-01-08T20:34:14Z | |
dc.date.issued | 1997-05-01 | en_US |
dc.identifier.citation | Clayton, Linda K.; Ghendler, Yoseph; Mizoguchi, Emiko; Patch, Raymond J.; Ocain, Timothy D.; Orth, Kim; Bhan, Atul K.; Dixit, Vishva M.; Reinherz, Ellis L. (1997). "T‐cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection." The EMBO Journal 16(9): 2282-2293. <http://hdl.handle.net/2027.42/102045> | en_US |
dc.identifier.issn | 0261-4189 | en_US |
dc.identifier.issn | 1460-2075 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/102045 | |
dc.publisher | John Wiley & Sons, Ltd | en_US |
dc.subject.other | Thymus | en_US |
dc.subject.other | Negative Selection | en_US |
dc.subject.other | Caspase | en_US |
dc.subject.other | Apoptosis | en_US |
dc.title | T‐cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 9171343 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/102045/1/emboj7590216.pdf | |
dc.identifier.doi | 10.1093/emboj/16.9.2282 | en_US |
dc.identifier.source | The EMBO Journal | en_US |
dc.identifier.citedreference | Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ ( 1991 ) bcl‐2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879 – 888. | en_US |
dc.identifier.citedreference | Shi Y, Bissonnette RP, Parfrey N, Szalay M, Kubo RT and Green DR ( 1991 ) In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol, 146, 3340 – 3346. | en_US |
dc.identifier.citedreference | Shinkai Y et al. ( 1992 ) Rag‐2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell, 68, 855 – 867. | en_US |
dc.identifier.citedreference | Sleath PR, Hendrickson RC, Kronheim SR, March CJ and Black RA ( 1990 ) Substrate specificity of the protease that processes human interleukin‐β. J Biol Chem, 265, 14526 – 14528. | en_US |
dc.identifier.citedreference | Smith CA, Williams GT, Kingston R, Jenkinson EJ and Owen JJ ( 1989 ) Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature, 337, 181 – 184. | en_US |
dc.identifier.citedreference | Smith KGC, Strasser A and Vaux DL ( 1996 ) CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO‐1)‐transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J, 15, 5167 – 5176. | en_US |
dc.identifier.citedreference | Steglich W and Hofle G ( 1969 ) N, N ‐dimethyl‐4‐pyridinamine, a very effective acylation catalyst. Angew Chem, Int Ed Engl, 8, 981. | en_US |
dc.identifier.citedreference | Steller H ( 1995 ) Mechanisms and genes of cellular suicide. Science, 267, 1445 – 1449. | en_US |
dc.identifier.citedreference | Surh CD and Sprent J ( 1994 ) T cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 372, 100 – 103. | en_US |
dc.identifier.citedreference | Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T and Nagata S ( 1994 ) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969 – 976. | en_US |
dc.identifier.citedreference | Tartaglia LA, Ayres TM, Wong GHW and Goeddel DV ( 1993 ) A novel domain within the 55 kDa TNF receptor signals cell death. Cell, 74, 845 – 853. | en_US |
dc.identifier.citedreference | Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM ( 1995 ) Yama/CPP32 β, a mammalian homolog of CED‐3, is a CrmA‐inhibitable protease that cleaves the death substrate poly(ADPribose) polymerase. Cell, 81, 801 – 809. | en_US |
dc.identifier.citedreference | Thornberry NA et al. ( 1992 ) A novel heterodimeric cysteine protease is required for interleukin‐1β processing in monocytes. Nature, 356, 768 – 774. | en_US |
dc.identifier.citedreference | Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR and Chapman KT ( 1994 ) Inactivation of interleukin‐1β converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry, 33, 3934 – 3940. | en_US |
dc.identifier.citedreference | Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH ( 1989 ) Monoclonal antibody‐mediated tumor regression by induction of apoptosis. Science, 245, 301 – 305. | en_US |
dc.identifier.citedreference | Vasquez NJ, Kaye J and Hedrick SM ( 1992 ) In vivo and in vitro clonal deletion of double positive thymocytes. J Exp Med, 175, 1307 – 1316. | en_US |
dc.identifier.citedreference | Vaux DL ( 1993 ) Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA, 90, 786 – 789. | en_US |
dc.identifier.citedreference | Vaux DL and Strasser A ( 1996 ) The molecular biology of apoptosis. Proc Natl Acad Sci USA, 93, 2239 – 2244. | en_US |
dc.identifier.citedreference | Vaux DL, Aguila HL and Weissman IL ( 1992 ) Bcl‐2 prevents death of factor‐deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol, 4, 821. | en_US |
dc.identifier.citedreference | Walker NPC et al. ( 1994 ) Crystal structure of the cysteine protease interleukin‐1β‐converting enzyme: a (p20/p10) 2 homodimer. Cell, 78, 343 – 352. | en_US |
dc.identifier.citedreference | Wang S, Miura M, Jung Y, Zhu H, Gagliardini V, Shi L, Greenberg AH and Yuan J ( 1996 ) Identification and characterization of Ich‐3, a member of the interleukin‐1β converting enzyme (ICE)/Ced‐3 family and an upstream regulator of ICE. J Biol Chem, 271, 20580 – 20587. | en_US |
dc.identifier.citedreference | Wilson KP et al. ( 1994 ) Structure and mechanism of interleukin‐β converting enzyme. Nature, 370, 270 – 275. | en_US |
dc.identifier.citedreference | Wyllie AH ( 1980 ) Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555 – 556. | en_US |
dc.identifier.citedreference | Yang E and Korsmeyer SJ ( 1996 ) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88, 386 – 401. | en_US |
dc.identifier.citedreference | Yonehara S, Ishii A and Yonehara M ( 1989 ) A cell‐killing monoclonal antibody (anti‐Fas) to a cell surface antigen co‐downregulated with the receptor of tumor necrosis factor. J Exp Med, 169, 1747 – 1756. | en_US |
dc.identifier.citedreference | Alderson MR, Tough TW, Braddy S, Davis ST, Roux E, Schooley K, Miller RE and Lynch DH ( 1994 ) Regulation of apoptosis and T cell activation by Fas‐specific mAb. Int Immunol, 6, 1799 – 1806. | en_US |
dc.identifier.citedreference | Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J ( 1996 ) Human ICE/CED‐3 protease nomenclature. Cell, 87, 171. | en_US |
dc.identifier.citedreference | Amakawa R et al. ( 1996 ) Impaired negative selection of T cells in Hodgkin's disease antigen CD30‐deficient mice. Cell, 84, 551 – 562. | en_US |
dc.identifier.citedreference | Ashton‐Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM and Tonegawa S ( 1994 ) Evidence for a differential avidity model of T cell selection in the thymus. Cell, 76, 651 – 663. | en_US |
dc.identifier.citedreference | Barlos K, Chatzi O, Gatos D and Stavropoulos G ( 1991 ) 2‐chlorotrityl chloride resin: studies on anchoring of Fmoc‐amino acids and peptide cleavage. Int J Pept Protein Res, 37, 513 – 520. | en_US |
dc.identifier.citedreference | Becker MLB, Near R, Mudgett‐Hunter M, Margolies MN, Kubo RT, Kaye J and Hedrick SM ( 1989 ) Expression of a hybrid immunoglobulin T cell receptor protein in transgenic mice. Cell, 58, 911 – 921. | en_US |
dc.identifier.citedreference | Bluestone JA ( 1995 ) New Perspectives of CD28‐B7‐mediated T cell costimulation. Immunity, 2, 555 – 559. | en_US |
dc.identifier.citedreference | Caputo A, James MNG, Powers JC, Hudig D and Bleackley RC ( 1994 ) Conversion of the substrate specificity of mouse proteinase granzyme B. Nature Struct Biol, 1, 364 – 367. | en_US |
dc.identifier.citedreference | Carpino LA ( 1993 ) 1‐Hydroxy‐7‐azabenzotriazole: an efficient peptide coupling additive. J Am Chem Soc, 115, 4397 – 4398. | en_US |
dc.identifier.citedreference | Carpino LA, El‐Faham A, Minor CA and Albericio F ( 1994 ) Advantageous applications of azabenzotriazole (triazolopyridine)‐based coupling reagents to solid phase peptide synthesis. J Chem Soc Chem Commun, 201 – 203. | en_US |
dc.identifier.citedreference | Chang H‐C et al. ( 1994 ) A general method for facilitating heterodimeric pairing between two proteins: application to expression of α and β T cell receptor extracellular segments. Proc Natl Acad Sci USA, 91, 11408 – 11412. | en_US |
dc.identifier.citedreference | Chapman KT ( 1992 ) Synthesis of a potent, reversible inhibitor of interleukin‐1β converting enzyme. Bioorg Med Chem Lett, 2, 613 – 618. | en_US |
dc.identifier.citedreference | Chinnaiyan AM, O'Rourke K, Yu G‐L, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J and Dixit VM ( 1996a ) Signal transduction by DR3, a death domain‐containing receptor related to TNFR‐1 and CD95. Science, 274, 990 – 992. | en_US |
dc.identifier.citedreference | Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kishkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM ( 1996b ) FADD/MORT1 is a common mediator of CD95 (Fas/APO‐1) and tumor necrosis factor receptor‐induced apoptosis. J Biol Chem, 271, 4961 – 4965. | en_US |
dc.identifier.citedreference | Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG and Dixit VM ( 1996c ) Molecular ordering of the cell death pathway: Bcl–2 and Bcl‐x L function upstream of the CED‐3‐like apoptotic proteases. J Biol Chem, 271, 4373 – 4576. | en_US |
dc.identifier.citedreference | Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W ( 1994 ) Current Protocols in Immunology John Wiley & Sons, New York. | en_US |
dc.identifier.citedreference | Crispe IN ( 1994 ) Fatal interactions: Fas‐induced apoptosis of immature T cells. Immunity, 1, 347 – 349. | en_US |
dc.identifier.citedreference | Darmon AJ, Nicholson DW and Bleackley RC ( 1995 ) Activation of the apoptotic protease CPP‐32 by cytotoxic T cell‐derived granzyme B. Nature, 377, 446 – 448. | en_US |
dc.identifier.citedreference | Degermann S, Surh CD, Glimcher LH, Sprent J and Lo D ( 1994 ) B7 expression on thymic medullary epithelium correlates with epithelium‐mediated deletion of Vβ5+ thymocytes. J Immunol, 152, 3254 – 3263. | en_US |
dc.identifier.citedreference | Dolle RE, Hoyer D, Prasad CV, Schmidt SJ, Helaszek CT, Miller RE and Ator MA ( 1994a ) P1 aspartate‐based peptide α‐((2,6‐dichlorobenzoyl)oxy)methyl ketones as potent time‐dependent inhibitors of interleukin‐1β‐converting enzyme. J Med Chem, 37, 563 – 564. | en_US |
dc.identifier.citedreference | Dolle RE et al. ( 1994b ) Aspartyl α‐((1‐phenyl‐3(trifluoromethyl)‐pyrazol‐5‐yl)osy)methyl ketones as interleukin‐1β‐converting enzyme inhibitors: significance of the P1 and P3 amino nitrogens for enzyme‐peptide inhibitor binding. J Med Chem, 37, 3863 – 3866. | en_US |
dc.identifier.citedreference | Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW and Dixit VM ( 1996a ) ICE‐LAP6, a novel member of the ICE/Ced‐3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem, 271, 16720 – 16724. | en_US |
dc.identifier.citedreference | Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He WW and Dixit VM ( 1996b ) ICE‐LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced‐3 is activated during Fas‐ and tumor necrosis factor‐induced apoptosis. J Biol Chem, 271, 1621 – 1625. | en_US |
dc.identifier.citedreference | Fearnhead HO, Dinsdale D and Cohen GM ( 1995 ) An interleukin‐1β converting enzyme‐like protease is a common mediator of apoptosis in thymocytes. FEBS Lett, 375, 283 – 288. | en_US |
dc.identifier.citedreference | Fernandes‐Alnemri T et al. ( 1996 ) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease and a substrate for granzyme B. Proc Natl Acad Sci USA, 93, 7464 – 7469. | en_US |
dc.identifier.citedreference | Fowlkes BJ and Pardoll DM ( 1989 ) Molecular and cellular events of T cell development. Adv Immunol, 44, 207 – 264. | en_US |
dc.identifier.citedreference | Fowlkes BJ, Schwartz RH and Pardoll DM ( 1988 ) Deletion of self‐reactive thymocytes occurs at a CD4 + 8 + precursor stage. Nature, 334, 620 – 623. | en_US |
dc.identifier.citedreference | Gavrieli Y, Sherman Y and Ben‐Sasson SA ( 1992 ) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol, 119, 493 – 501. | en_US |
dc.identifier.citedreference | Hanson RD and Ley TJ ( 1990 ) Transcriptional activation of the human cytotoxic serine protease gene CSP‐B in T lymphocytes. Mol Cell Biol, 10, 5655 – 5662. | en_US |
dc.identifier.citedreference | Hanson RD, Sclar GM, Kanagawa O and Ley TJ ( 1991 ) The 5′ flanking region of the human CGL‐1/granzyme B gene targets expression of a reporter gene to activated T lymphocytes in transgenic mice. J Biol Chem, 266, 24433 – 24438. | en_US |
dc.identifier.citedreference | Henkart PA ( 1996 ) ICE family proteases: mediators of all apoptotic cell death? Immunity, 4, 195 – 201. | en_US |
dc.identifier.citedreference | Heusel JW, Hanson RD, Silverman GA and Ley TJ ( 1991 ) Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem, 266, 61l52 – 6158. | en_US |
dc.identifier.citedreference | Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ and Carbone FR ( 1994 ) T cell receptor antagonist peptides induce positive selection. Cell, 76, 17 – 27. | en_US |
dc.identifier.citedreference | Howard AD et al. ( 1991 ) IL‐1 converting enzyme requires aspartic acid residues for processing of the IL‐1β precursor at two distinct sites and does not cleave 31‐kDa IL‐1α. J Immunol, 147, 2964 – 2969. | en_US |
dc.identifier.citedreference | Itoh N and Nagata S ( 1993 ) A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J Biol Chem, 268, 10932 – 10937. | en_US |
dc.identifier.citedreference | Kappler JW, Roehm N and Marrack P ( 1987 ) T cell tolerance by clonal elimination in the thymus. Cell, 49, 273 – 280. | en_US |
dc.identifier.citedreference | Kisielow P, Bluthmann H, Staerz UD, Steinmetz M and von Boehmer H ( 1988 ) Tolerance in T cell receptor transgenic mice involves deletion of nonmature CD4 + CD8 + thymocytes. Nature, 333, 742 – 746. | en_US |
dc.identifier.citedreference | Krantz A, Copp LJ, Coles PJ, Smith RA and Heard SB ( 1991 ) Peptidyl(acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases. Biochemistry, 30, 4678 – 4687. | en_US |
dc.identifier.citedreference | Kuida K, Lippke JA, Ku G, Harding MW and Livingston DJ, Su MS‐S, Flavell RA ( 1995 ) Altered cytokine export and apoptosis in mice deficient in interleukin‐1β converting enzyme. Science, 267, 2000 – 2003. | en_US |
dc.identifier.citedreference | Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P and Flavell RA ( 1996 ) Decreased apoptosis in the brain and premature lethality in CPP32‐deficient mice. Nature, 384, 368 – 372. | en_US |
dc.identifier.citedreference | Lerner A, Clayton LK, Mizoguchi E, Ghendler Y, von Ewik W, Koyasu S, Bhan AK and Reinherz EL ( 1996 ) Cross‐linking of T‐cell receptors on double‐positive thymocytes induces a cytokine‐mediated stromal activation process linked to cell death. EMBO J, 15, 5876 – 5877. | en_US |
dc.identifier.citedreference | Li P et al. ( 1995 ) Mice deficient in IL‐1β‐converting enzyme are defective in production of mature IL‐1β and resistant to endotoxic shock. Cell, 80, 401 – 411. | en_US |
dc.identifier.citedreference | Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler AC and Bhan AK ( 1996 ) Cytokine imbalance and autoantibody production in T cell receptor α mutant mice and inflammatory bowel disease. J Exp Med, 183, 847 – 856. | en_US |
dc.identifier.citedreference | Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK and Tonegawa S ( 1993 ) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell, 75, 275 – 282. | en_US |
dc.identifier.citedreference | Murphy KM, Heimberger AB and Loh DY ( 1990 ) Induction by antigen of intrathymic apoptosis of CD4 + CD8 + TCR low thymocytes in vivo. Science, 250, 1720 – 1723. | en_US |
dc.identifier.citedreference | Murphy MEP, Moult J, Bleackley RC, Gershenfeld H, Weissman IL and James MNG ( 1988 ) Comparative molecular model building of two serine proteases from cytotoxic T lymphocytes. Proteins Struct Funct Genet, 4, 190 – 204. | en_US |
dc.identifier.citedreference | Muzio M et al. ( 1996 ) FLICE, a novel FADD‐homologous ICE/CED‐3‐like protease, is recruited to the CD95 (Fas/APO‐1) death‐inducing signaling complex. Cell, 85, 817 – 827. | en_US |
dc.identifier.citedreference | Nalin CM ( 1995 ) Apoptosis research enters the ICE age. Structure, 3, 143 – 145. | en_US |
dc.identifier.citedreference | Nicholson DW et al. ( 1995 ) Identification and inhibition of the ICE/CED‐3 protease necessary for mammalian apoptosis. Nature, 376, 37 – 43. | en_US |
dc.identifier.citedreference | Nossal GJV ( 1994 ) Negative selection of lymphocytes. Cell, 76, 229 – 239. | en_US |
dc.identifier.citedreference | Odake S, Kam CM, Narasimhan L, Poe M, Blake JT, Krahenbuhl O, Tschopp J and Powers JC ( 1991 ) Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry, 30, 2217 – 2227. | en_US |
dc.identifier.citedreference | Orth K, Chinnaiyan AM, Garg M, Froelich CJ and Dixit VM ( 1996a ) The CED‐3/ICE‐like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem, 271, 16443 – 16446. | en_US |
dc.identifier.citedreference | Orth K, O'Rourke K, Salvesen GS and Dixit VM ( 1996b ) Molecular ordering of apoptotic mammalian CED‐3/ICE‐like proteases. J Biol Chem, 271, 20977 – 20980. | en_US |
dc.identifier.citedreference | Page DM, Kane LP, Allison JP and Hedrick SM ( 1993 ) Two signals are required for negative selection of CD4 + CD8 + thymocytes. J Immunol, 151, 1868 – 1880. | en_US |
dc.identifier.citedreference | Patten PA, Rock EP, Sonoda T, Fazekas de St Groth B, Jorgensen JL and Davis MM ( 1993 ) Transfer of putative complementarity‐determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J Immunol, 150, 2281 – 2294. | en_US |
dc.identifier.citedreference | Pronk GJ, Ramer K, Amiri P and Williams LT ( 1996 ) Requirement of an ICE‐like protease for induction of apoptosis and ceramide generation by REAPER. Science, 271, 808 – 810. | en_US |
dc.identifier.citedreference | Punt JA, Osborne BA, Takahama Y, Sharrow SO and Singer A ( 1994 ) Negative selection of CD4 + CD8 + thymocytes by T cell receptor‐induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med, 179, 709 – 713. | en_US |
dc.identifier.citedreference | Quan LT, Tewari M, O'Rourke K, Dixit VM, Snipas SJ, Poirier GG, Ray C, Pickup DJ and Salvesen GS ( 1996 ) Proteolytic activation of the cell death protease Yama/CPP‐32 by granzyme B. Proc Natl Acad Sci USA, 93, 1972 – 1976. | en_US |
dc.identifier.citedreference | Ramarli D, Fox DA and Reinherz EL ( 1987 ) Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism. Proc Natl Acad Sci USA, 84, 8598 – 8602. | en_US |
dc.identifier.citedreference | Rotonda J et al. ( 1996 ) The three dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct Biol, 3, 619 – 625. | en_US |
dc.identifier.citedreference | Rozzo AJ, Eisenberg RA, Cohen PL and Kotzin BL ( 1994 ) Development of the T cell receptor repertoire in lpr mice. Semin Immunol, 6, 19 – 26. | en_US |
dc.identifier.citedreference | Sarin A, Wu M‐L and Henkart PA ( 1996 ) Different interleukin‐1β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med, 184, 2445 – 2450. | en_US |
dc.identifier.citedreference | Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T‐T and Nicholson DW ( 1996 ) CPP‐32/apopain is the key interleukin‐1β‐converting enzyme‐like protease involved in Fas‐mediated apoptosis. J Biol Chem, 271, 1841 – 1844. | en_US |
dc.identifier.citedreference | Sebzda E, Wallace VA, Mayer J, Yeung RS, Mak TW and Ohashi PS ( 1994 ) Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science, 263, 1615 – 1618. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.